|
|
Volumn 14, Issue 8, 2015, Pages 515-516
|
|
Bacteriophage therapies re-enter clinical trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
SULFADIAZINE SILVER;
ANTIBIOTIC RESISTANCE;
BACTERIAL STRAIN;
BACTERIOPHAGE;
CLINICAL TRIAL (TOPIC);
DRUG CONTROL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
ESCHERICHIA COLI INFECTION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOMONAS INFECTION;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
TREATMENT OUTCOME;
BACTERIAL INFECTIONS;
MICROBIOLOGY;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BACTERIOPHAGES;
CLINICAL TRIALS AS TOPIC;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
|
|
EID: 84938408259
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4695 Document Type: Short Survey |
|
Times cited : (57)
|
|
References (0)
|
